Does T helper differentiation correlate with resistance or susceptibility to infection with L. Major? Some insights from the murine model

Frontiers in Immunology

Volumn 3, Issue FEB, 2012, Pages

  Tacchini Cottier, Fabienne ^a   Weinkopff, Tiffany ^a   Launois, Pascal ^a,b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

L. Major, T helper cells, TH1, TH2, TH17, Treg, IL 17; Leishmania

Indexed keywords

EID: 84867096276     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00032     Document Type: Review

References (97)

1. Alexander, J., and Bryson, K. (2005). T helper (h)1/Th2 and Leish-mania: paradox rather than paradigm. Immunol. Lett. 99, 17-23.
2. Allenbach, C., Launois, P., Mueller, C., and Tacchini-Cottier, F. (2008). An essential role for transmembrane TNF in the resolution of the inflam-matory lesion induced by Leishma-nia major infection. Eur. J. Immunol. 38, 720-731.
3. Anderson, C. F., Mendez, S., and Sacks, D. L. (2005). Non-healing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice. J. Immunol. 174, 2934-2941.
4. Anderson, C. F., Stumhofer, J. S., Hunter, C. A., and Sacks, D. (2009). IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishma-nia major infection. J. Immunol. 183, 4619-4627.
5. Artis, D., Johnson, L. M., Joyce, K., Saris, C., Villarino, A., Hunter, C. A., and Scott, P. (2004). Cutting edge: early IL-4 production governs the require-ment for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leish-mania major infection. J. Immunol. 172, 4672-4675.
6. Aseffa, A., Gumy, A., Launois, P., MacDonald, H. R., Louis, J. A., and Tacchini-Cottier, F. (2002). The early IL-4 response to Leishmania major and the resulting Th2 cell matu-ration steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells. J. Immunol. 169, 3232-3241.
7. Beil, W. J., Meinardus-Hager, G., Neuge-bauer, D. C., and Sorg, C. (1992). Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and sus-ceptible mice. J. Leukoc. Biol. 52, 135-142.
8. Belkaid, Y., Hoffmann, K. F., Mendez, S., Kamhawi, S., Udey, M. C., Wynn, T. A., and Sacks, D. L. (2001). The role of interleukin (IL)-10 in the per-sistence of Leishmania major in the skin after healing and the therapeu-tic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194, 1497-1506.
9. Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M., and Sacks, D. L. (2002). CD4+CD25+ regulatory T cells control Leishmania major per-sistence and immunity. Nature 420, 502-507.
10. Belosevic, M., Finbloom, D., Van Der Meide, P., Slayter, M., and Nacy, C. (1989). Administration of mono-clonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143, 266-274.
11. Bogdan, C., Gessner, A., Solbach, W., and Rollinghoff, M. (1996). Inva-sion, control and persistence of Leishmania parasites. Curr. Opin. Immunol. 8, 517-525.
12. Campbell, D. J., and Koch, M. A. (2011). Treg cells: patrolling a dan-gerous neighborhood. Nat. Med. 17, 929-930.
13. Chakour, R., Guler, R., Bugnon, M., Allenbach, C., Garcia, I., Mauel, J., Louis, J., and Tacchini-Cottier, F. (2003). Both the Fas ligand and inducible nitric oxide syn-thase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal. Infect. Immun. 71, 5287-5295.
14. Charmoy, M., Auderset, F., Allenbach, C., and Tacchini-Cottier, F. (2010). The prominent role of neutrophils during the initial phase of infection by Leishmania parasites. J. Biomed. Biotechnol. 2010, 719361.
15. Ghoreschi, K., Laurence, A., Yang, X. P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., David-son, T. S., Bouladoux, N., Grainger, J. R., Chen, Q., Kanno, Y., Watford, W. T., Sun, H. W., Eberl, G., Shevach, E. M., Belkaid, Y., Cua, D. J., Chen, W., and O'shea, J. J. (2010). Gener-ation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467, 967-971.
16. Groux, H., Cottrez, F., Rouleau, M., Mauze, S., Antonenko, S., Hurst, S., McNeil, T., Bigler, M., Roncar-olo, M. G., and Coffman, R. L. (1999). A transgenic model to ana-lyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol. 162, 1723-1729.
17. Hagenbaugh, A., Sharma, S., Dubinett, S. M., Wei, S. H., Aranda, R., Cher-outre, H., Fowell, D. J., Binder, S., Tsao, B., Locksley, R. M., Moore, K. W., and Kronenberg, M. (1997). Altered immune responses in inter-leukin 10 transgenic mice. J. Exp. Med. 185, 2101-2110.
18. Heinzel, F. P., and Maier, R. A. Jr. (1999). Interleukin-4-independent acceleration of cutaneous leish-maniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody. Infect. Immun. 67, 6454-6460.
19. Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L., and Locksley, R. M. (1989). Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169, 59-72.
20. Heinzel, F. P., Schoenhaut, D. S., Rerko, R. M., Rosser, L. E., and Gately, M. K. (1993). Recombinant inter-leukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177, 1505-1509.
21. Himmelrich, H., Launois, P., Maillard, I., Biedermann, T., Tacchini-Cottier, F., Locksley, R. M., Rocken, M., and Louis, J. A. (2000). In BALB/c mice, IL-4 production during the initial phase of infection with Leishma-nia major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J. Immunol. 164, 4819-4825.
22. Hirota, K., Martin, B., and Veldhoen, M. (2010). Development, regula-tion and functional capacities of Th17 cells. Semin. Immunopathol. 32, 3-16.
23. Jacobson, N. G., Szabo, S. J., Weber-Nordt, R. M., Zhong, Z., Schreiber, R. D., Darnell, J. E. Jr., and Murphy, K. M. (1995). Interleukin 12 signal-ing in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J. Exp. Med. 181, 1755-1762.
24. Julia, V., Rassoulzadegan, M., and Glaichenhaus, N. (1996). Resistance to Leishmania major induced by tol-erance to a single antigen. Science 274, 421-423.
25. Kanaly, S. T., Nashleanas, M., Hondow-icz, B., and Scott, P. (1999). TNF receptor p55 is required for elimina-tion of inflammatory cells following control of intracellular pathogens. J. Immunol. 163, 3883-3889.
26. Kane, M. M., and Mosser, D. M. (2001). The role of IL-10 in promoting dis-ease progression in leishmaniasis. J. Immunol. 166, 1141-1147.
27. Kelly, B. L., and Locksley, R. M. (2004). The Leishmania major LACK anti-gen with an immunodominant epi-tope at amino acids 156 to 173 is not required for early Th2 development in BALB/c mice. Infect. Immun. 72, 6924-6931.
28. Kopf, M., Brombacher, F., Kohler, G., Kienzle, G., Widmann, K. H., Lefrang, K., Humborg, C., Leder-mann, B., and Solbach, W. (1996). IL-4-deficient Balb/c mice resist infection with Leishmania major. J. Exp. Med. 184, 1127-1136.
29. Korn, T., Bettelli, E., Oukka, M., and Kuchroo, V. K. (2009). IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517.
30. Kropf, P., Herath, S., Klemenz, R., and Muller, I. (2003). Signaling through the T1/ST2 molecule is not neces-sary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishma-nia major infection. Infect. Immun. 71, 1961-1971.
31. Kropf, P., Schopf, L. R., Chung, C. L., Xu, D., Liew, F. Y., Sypek, J. P., and Muller, I. (1999). Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection. Eur. J. Immunol. 29, 3621-3628.
32. Laskay, T., Rollinghoff, M., and Solbach, W. (1993). Natural killer cells par-ticipate in the early defense against Leishmania major infection in mice. Eur. J. Immunol. 23, 2237-2241.
33. Launois, P., Gumy, A., Himmelrich, H., Locksley, R. M., Rocken, M., and Louis, J. A. (2002). Rapid IL-4 production by Leishmania homolog of mammalian RACK1-reactive CD4(+) T cells in resis-tant mice treated once with anti-IL-12 or -IFN-gamma antibodies at the onset of infection with Leishma-nia major instructs Th2 cell devel-opment, resulting in nonhealing lesions. J. Immunol. 168, 4628-4635.
34. Launois, P., Maillard, I., Pingel, S., Swi-hart, K. G., Xenarios, I., Acha-Orbea, H., Diggelmann, H., Locksley, R. M., MacDonald, H. R., and Louis, J. A. (1997a). IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ Tcells instructs Th2 development and sus-ceptibility to Leishmania major in BALB/c mice. Immunity 6, 541-549.
35. Launois, P., Swihart, K. G., Milon, G., and Louis, J. A. (1997b). Early production of IL-4 in suscepti-ble mice infected with Leishma-nia major rapidly induces IL-12 unresponsiveness. J. Immunol. 158, 3317-3324.
36. Leal, L. M., Moss, D. W., Kuhn, R., Muller, W., and Liew, F. Y. (1993). Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur. J. Immunol. 23, 566-569.
37. Li, Y., Ishii, K., Hisaeda, H., Hamano, S., Zhang, M., Nakanishi, K., Yoshi-moto, T., Hemmi, H., Takeda, K., Akira, S., Iwakura, Y., and Himeno, K. (2004). IL-18 gene therapy devel-ops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9? Gene Ther. 11, 941-948.
38. Liu, H., Hu, B., Xu, D., and Liew, F. Y. (2003). CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4. J. Immunol. 171, 5012-5017.
39. Lochner, M., Peduto, L., Cherrier, M., Sawa, S., Langa, F., Varona, R., Rieth-macher, D., Si-Tahar, M., Di Santo, J. P., and Eberl, G. (2008). In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J. Exp. Med. 205, 1381-1393.
40. Lopez Kostka, S., Dinges, S., Griewank, K., Iwakura, Y., Udey, M. C., and Von Stebut, E. (2009). IL-17 promotes progression of cutaneous leishmani-asis in susceptible mice. J. Immunol. 182, 3039-3046.
41. Matthews, D. J., Emson, C. L., McKen-zie, G. J., Jolin, H. E., Blackwell, J. M., and McKenzie, A. N. (2000). IL-13 is a susceptibility factor for Leishma-nia major infection. J. Immunol. 164, 1458-1462.
42. Mattner, F., Di Padova, K., and Alber, G. (1997). Interleukin-12 is indispens-able for protective immunity against Leishmania major. Infect. Immun. 65, 4378-4383.
43. Mattner, F., Magram, J., Ferrante, J., Launois, P., Di Padova, K., Behin, R., Gately, M. K., Louis, J. A., and Alber, G. (1996). Genetically resis-tant mice lacking interleukin-12 are susceptible to infection with Leish-mania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26, 1553-1559.
44. Mitchell, G. F., Curtis, J. M., Scollay, R. G., and Handman, E. (1981). Resistance and abrogation of resis-tance to cutaneous leishmaniasis in reconstituted BALB/c nude mice. Aust. J. Exp. Biol. Med. Sci. 59, 539-554.
45. Monteforte, G. M., Takeda, K., Rodriguez-Sosa, M., Akira, S., David, J. R., and Satoskar, A. R. (2000). Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection. J. Immunol. 164, 5890-5893.
46. Morris, L., Aebischer, T., Handman, E., and Kelso, A. (1993). Resis-tance of BALB/c mice to Leish-mania major infection is associ-ated with a decrease in the pre-cursor frequency of antigen-specific CD4+ cells secreting interleukin-4. Int. Immunol. 5, 761-767.
47. Mosmann, T., Cherwinski, H., Bond, M., Giedlin, M., and Coffman, R. (1986). Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357.
48. Mougneau, E., Altare, F., Wakil, A. E., Zheng, S., Coppola, T., Wang, Z. E., Waldmann, R., Locksley, R. M., and Glaichenhaus, N. (1995). Expression cloning of a protective Leishmania antigen. Science 268, 563-566.
49. Nagase, H., Jones, K. M., Anderson, C. F., and Noben-Trauth, N. (2007). Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility. J. Immunol. 179, 2435-2444.
50. Nakanishi, K., Yoshimoto, T., Tsut-sui, H., and Okamura, H. (2001). Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19, 423-474.
51. Nashleanas, M., Kanaly, S., and Scott, P. (1998). Control of Leishmania major infection in mice lacking TNF receptors. J. Immunol. 160, 5506-5513.
52. Noben-Trauth, N., Kropf, P., and Muller, I. (1996). Susceptibility to Leishma-nia major infection in interleukin-4-deficient mice. Science 271, 987-990.
53. Noben-Trauth, N., Lira, R., Nagase, H., Paul, W. E., and Sacks, D. L. (2003). The relative contribution of IL-4 receptor signaling and IL-10 to sus-ceptibility to Leishmania major. J. Immunol. 170, 5152-5158.
54. Noben-Trauth, N., Paul, W. E., and Sacks, D. L. (1999). IL-4-and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major para-site substrains. J. Immunol. 162, 6132-6140.
55. Nylen, S., Khamesipour, A., Moham-madi, A., Jafari-Shakib, R., Eidsmo, L., Noazin, S., Modabber, F., and Akuffo, H. (2006). Surrogate mark-ers of immunity to Leishma-nia major in leishmanin skin test negative individuals from an endemic area re-visited. Vaccine 24, 6944-6954.
56. Ohkusu, K., Yoshimoto, T., Takeda, K., Ogura, T., Kashiwamura, S., Iwakura, Y., Akira, S., Okamura, H., and Nakanishi, K. (2000). Potentiality of interleukin-18 as a useful reagent for treatment and prevention of Leishmania major infection. Infect. Immun. 68, 2449-2456.
57. O'Shea, J. J., and Paul, W. E. (2010). Mechanisms underlying lin-eage commitment and plasticity of helper CD4+ T cells. Science 327, 1098-1102.
58. Pakpour, N., Zaph, C., and Scott, P. (2008). The central memory CD4+ T cell population generated during Leishmania major infection requires IL-12 to produce IFN-gamma. J. Immunol. 180, 8299-8305.
59. Park, A. Y., Hondowicz, B., Kopf, M., and Scott, P. (2002). The role of IL-12 in maintaining resistance to Leishmania major. J. Immunol. 168, 5771-5777.
60. Park, A. Y., Hondowicz, B. D., and Scott, P. (2000). IL-12 is required to main-tain a Th1 response during Leishma-nia major infection. J. Immunol. 165, 896-902.
61. Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L., Churakova, T., Travis, M., Vaisberg, E., Blumenschein, W. M., Mattson, J. D., Wagner, J. L., To, W., Zurawski, S., McClanahan, T. K., Gorman, D. M., Bazan, J. F., De Waal Malefyt, R., Rennick, D., and Kastelein, R. A. (2002). IL-27, a het-erodimeric cytokine composed of EBI3 and p28 protein, induces pro-liferation of naive CD4(+) T cells. Immunity 16, 779-790.
62. Pollock, K. G., McNeil, K. S., Mottram, J. C., Lyons, R. E., Brewer, J. M., Scott, P., Coombs, G. H., and Alexander, J. (2003). The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses. J. Immunol. 170, 1746-1753.
63. Radwanska, M., Cutler, A. J., Hoving, J. C., Magez, S., Holscher, C., Bohms, A., Arendse, B., Kirsch, R., Hunig, T., Alexander, J., Kaye, P., and Brom-bacher, F. (2007). Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection. PLoS Pathog. 3, e68. doi:10.1371/journal.ppat.0030068.
64. Ribeiro-Gomes, F. L., Otero, A. C., Gomes, N. A., Moniz-De-Souza, M. C., Cysne-Finkelstein, L., Arnholdt, A. C., Calich, V. L., Coutinho, S. G., Lopes, M. F., and Dosreis, G. A. (2004). Macrophage interactions with neutrophils regulate Leishma-nia major infection. J. Immunol. 172, 4454-4462.
65. Ritter, U., Mattner, J., Rocha, J. S., Bog-dan, C., and Korner, H. (2004). The control of Leishmania (Leishmania) major by TNF in vivo is depen-dent on the parasite strain. Microbes Infect. 6, 559-565.
66. Ronet, C., Hauyon-La Torre, Y., Revaz-Breton, M., Mastelic, B., Tacchini-Cottier, F., Louis, J., and Launois, P. (2010). Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J. Immunol. 184, 886-894.
67. Sacks, D., and Noben-Trauth, N. (2002). The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2, 845-858.
68. Sadick, M. D., Heinzel, F. P., Holaday, B. J., Pu, R. T., Dawkins, R. S., and Lock-sley, R. M. (1990). Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J. Exp. Med. 171, 115-127.
69. Sadick, M. D., Street, N., Mosmann, T. R., and Locksley, R. M. (1991). Cytokine regulation of murine leish-maniasis: interleukin 4 is not suffi-cient to mediate progressive disease in resistant C57BL/6 mice. Infect. Immun. 59, 4710-4714.
70. Sakai, T., Hisaeda, H., Nakano, Y., Ishikawa, H., Maekawa, Y., Ishii, K., Nitta, Y., Miyazaki, J., and Himeno, K. (2000). Gene gun-mediated deliv-ery of an interleukin-12 expression plasmid protects against infections with the intracellular protozoan par-asites Leishmania major and Try-panosoma cruzi in mice. Immunol-ogy 99, 615-624.
71. Satoskar, A. R., Stamm, L. M., Zhang, X., Satoskar, A. A., Okano, M., Ter-horst, C., David, J. R., and Wang, B. (1999). Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection. J. Immunol. 162, 6747-6754.
72. Scharton-Kersten, T., and Scott, P. (1995). The role of the innate immune response in Th1 cell development following Leishmania major infection. J. Leukoc. Biol. 57, 515-522.
73. Scott, P. (1991). IFN-gamma modu-lates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147, 3149-3155.
74. Scott, P., Eaton, A., Gause, W. C., Di Zhou, X., and Hondowicz, B. (1996). Early IL-4 production does not predict susceptibility to Leishmania major. Exp. Parasitol. 84, 178-187.
75. Scott, P., Natovitz, P., Coffman, R. L., Pearce, E., and Sher, A. (1988). Immunoregulation of cutaneous leishmaniasis. T cell lines that trans-fer protective immunity or exacer-bation belong to different T helper subsets and respond to distinct par-asite antigens. J. Exp. Med. 168, 1675-1684.
76. Stamm, L. M., Satoskar, A. A., Ghosh, S. K., David, J. R., and Satoskar, A. R. (1999). STAT-4 mediated IL-12 signaling pathway is critical for the development of protective immu-nity in cutaneous leishmaniasis. Eur. J. Immunol. 29, 2524-2529.
77. Stetson, D. B., Mohrs, M., Mallet-Designe, V., Teyton, L., and Locksley, R. M. (2002). Rapid expansion and IL-4 expression by Leishmania-specific naive helper T cells in vivo. Immunity 17, 191-200.
78. Stobie, L., Gurunathan, S., Prussin, C., Sacks, D. L., Glaichenhaus, N., Wu, C. Y., and Seder, R. A. (2000). The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protec-tion to an infectious parasite chal-lenge. Proc. Natl. Acad. Sci. U.S.A. 97, 8427-8432.
79. Suffia, I., Reckling, S. K., Salay, G., and Belkaid, Y. (2005). A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J. Immunol. 174, 5444-5455.
80. Swihart, K., Fruth, U., Messmer, N., Hug, K., Behin, R., Huang, S., Del Giudice, G., Aguet, M., and Louis, J. A. (1995). Mice from a genet-ically resistant background lacking the interferon gamma receptor are susceptible to infection with Leish-mania major but mount a polar-ized T helper cell 1-type CD4+ T cell response. J. Exp. Med. 181, 961-971.
81. Sypek, J. P., Chung, C. L., Mayor, S. E., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. F., and Schaub, R. G. (1993). Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177, 1797-1802.
82. Szabo, S. J., Sullivan, B. M., Stem-mann, C., Satoskar, A. R., Sleck-man, B. P., and Glimcher, L. H. (2002). Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295, 338-342.
83. Tacchini-Cottier, F., Zweifel, C., Belkaid, Y., Mukankundiye, C., Vasei, M., Launois, P., Milon, G., and Louis, J. A. (2000). An immunomodula-tory function for neutrophils dur-ing the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major. J. Immunol. 165, 2628-2636.
84. Trinchieri, G., Pflanz, S., and Kastelein, R.A. (2003). The IL-12 family of het-erodimeric cytokines: new players in the regulation of T cell responses. Immunity 19, 641-644.
85. Uyttenhove, C., Marillier, R. G., Tacchini-Cottier, F., Charmoy, M., Caspi, R. R., Damsker, J. M., Goriely, S., Su, D., Van Damme, J., Struyf, S., Opdenakker, G., and Van Snick, J. (2011). Amine-reactive OVA mul-timers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection. J. Leukoc. Biol. 89, 1001-1007.
86. Uzonna, J. E., Joyce, K. L., and Scott, P. (2004). Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. J. Exp. Med. 199, 1559-1566.
87. Vieira, L. Q., Goldschmidt, M., Nash-leanas, M., Pfeffer, K., Mak, T., and Scott, P. (1996). Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control par-asite replication. J. Immunol. 157, 827-835.
88. Wakil, A. E., Wang, Z. E., Ryan, J. C., Fowell, D. J., and Locksley, R. M. (1998). Interferon gamma derived from CD4(+) T cells is sufficient to mediate T helper cell type 1 development. J. Exp. Med. 188, 1651-1656.
89. Wang, Z. E., Reiner, S. L., Zheng, S., Dalton, D. K., and Locksley, R. M. (1994). CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J. Exp. Med. 179, 1367-1371.
90. Wei, X. Q., Niedbala, W., Xu, D., Luo, Z. X., Pollock, K. G., and Brewer, J. M. (2004). Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection. Immunol. Lett. 94, 35-37.
91. Wilhelm, P., Ritter, U., Labbow, S., Don-hauser, N., Rollinghoff, M., Bog-dan, C., and Korner, H. (2001). Rapidly fatal leishmaniasis in resis-tant C57BL/6 mice lacking TNF. J. Immunol. 166, 4012-4019.
92. Wu, W., Huang, L., and Mendez, S. (2010). A live Leishmania major vac-cine containing CpG motifs induces the de novo generation of Th17 cells in C57BL/6 mice. Eur. J. Immunol. 40, 2517-2527.
93. Xu, D., Liu, H., Komai-Koma, M., Campbell, C., McSharry, C., Alexander, J., and Liew, F. Y. (2003). CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J. Immunol. 170, 394-399.
94. Xu, D., Trajkovic, V., Hunter, D., Leung, B. P., Schulz, K., Gracie, J. A., McInnes, I. B., and Liew, F. Y. (2000). IL-18 induces the differenti-ation of Th1 or Th2 cells depending upon cytokine milieu and genetic background. Eur. J. Immunol. 30, 3147-3156.
95. Yang, X. O., Nurieva, R., Martinez, G. J., Kang, H. S., Chung, Y., Pappu, B. P., Shah, B., Chang, S. H., Schluns, K. S., Watowich, S. S., Feng, X. H., Jetten, A. M., and Dong, C. (2008). Molecular antagonism and plasticity of regulatory and inflamma-tory T cell programs. Immunity 29, 44-56.
96. Yoshida, H., Hamano, S., Senaldi, G., Covey, T., Faggioni, R., Mu, S., Xia, M., Wakeham, A. C., Nishina, H., Potter, J., Saris, C. J., and Mak, T. W. (2001). WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15, 569-578.
97. Zhou, Y. (2008). Regulatory T cells and viral infections. Front. Biosci. 13, 1152-1170.